These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23495097)

  • 1. Levetiracetam-responsive myoclonus in spinocerebellar ataxia type 15.
    Orsucci D; Ienco EC; Rocchi A; Siciliano G; Mancuso M; Bonuccelli U
    Mov Disord; 2013 Sep; 28(10):1465. PubMed ID: 23495097
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of myoclonus in SCA2 by piracetam.
    De Rosa A; Striano P; Barbieri F; de Falco A; Rinaldi C; Tucci T; Striano S; Filla A; De Michele G
    Mov Disord; 2006 Jan; 21(1):116-8. PubMed ID: 16149096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of levetiracetam in the management of post-anoxic myoclonias. A report of two cases].
    Lay-Son Rivas L; Pizarro Segura J; Meza Flores R
    Neurologia; 2007 Dec; 22(10):915-6. PubMed ID: 18040909
    [No Abstract]   [Full Text] [Related]  

  • 4. Dramatic effect of levetiracetam on posthypoxic myoclonus: difficult weaning from mechanical ventilation.
    Muslu B; Kilci O; Horasanli E; Dikmen B
    Clin Neuropharmacol; 2009; 32(4):236. PubMed ID: 19644236
    [No Abstract]   [Full Text] [Related]  

  • 5. Levetiracetam control of myoclonus in a patient with Creutzfeldt-Jakob disease.
    Imperiale D; Bortolotto S; Cucatto A; Schiffer P; Cassano D; Buffa C
    Eur Neurol; 2003; 49(3):189-90. PubMed ID: 12646771
    [No Abstract]   [Full Text] [Related]  

  • 6. Amelioration of spinal myoclonus with levetiracetam.
    Keswani SC; Kossoff EH; Krauss GL; Hagerty C
    J Neurol Neurosurg Psychiatry; 2002 Oct; 73(4):457-8. PubMed ID: 12235322
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of early diagnosed post-anoxic myoclonus with levetiracetam.
    Venot M; Weiss N; Espinoza S; Imbert A; Tadie JM; Fagon JY; Guerot E; Diehl JL
    Intensive Care Med; 2011 Jan; 37(1):177-9. PubMed ID: 20871977
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of levetiracetam in the treatment of two cases of hypoxic encephalopathy with myoclonic status].
    de Gea-García JH; Villegas I; Sánchez Cámara S; Martínez Fresneda M
    Med Intensiva; 2011; 35(6):393-4. PubMed ID: 21296455
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of amiodarone-associated myoclonus responsive to levetiracetam.
    Deik AF; Shanker VL
    Can J Neurol Sci; 2012 Sep; 39(5):680-1. PubMed ID: 23066555
    [No Abstract]   [Full Text] [Related]  

  • 10. Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases.
    Kovács T; Farsang M; Vitaszil E; Barsi P; Györke T; Szirmai I; Kamondi A
    J Neural Transm (Vienna); 2009 Dec; 116(12):1631-4. PubMed ID: 19756367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of encephalopathy and myoclonus with levetiracetam in a case of subacute sclerosing panencephalitis.
    Becker D; Patel A; Abou-Khalil BW; Pina-Garza JE
    J Child Neurol; 2009 Jun; 24(6):763-7. PubMed ID: 19151368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postanoxic myoclonus: two case presentations and review of medical management.
    Budhram A; Lipson D; Nesathurai S; Harvey D; Rathbone MP
    Arch Phys Med Rehabil; 2014 Mar; 95(3):588-90. PubMed ID: 24060492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical challenge of posthypoxic myoclonus.
    Frucht SJ
    Adv Neurol; 2002; 89():85-8. PubMed ID: 11968475
    [No Abstract]   [Full Text] [Related]  

  • 14. Limited efficacy of levetiracetam on myoclonus of different etiologies.
    Lim LL; Ahmed A
    Parkinsonism Relat Disord; 2005 Mar; 11(2):135-7. PubMed ID: 15734675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of post-hypoxic action myoclonus with levetiracetam add-on therapy: A case report.
    Božić K; Gebauer-Bukurov K; Sakalaš L; Divjak I; Ješić A
    Vojnosanit Pregl; 2014 May; 71(5):515-9. PubMed ID: 26137720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam as alternative treatment in Jeavons syndrome.
    Parissis D; Ioannidis P; Karacostas D
    J Neurol Sci; 2014 Jun; 341(1-2):147-9. PubMed ID: 24798222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam.
    Kobayashi K; Takeuchi A; Oka M; Akiyama M; Ohtsuka Y
    Brain Dev; 2012 May; 34(5):368-71. PubMed ID: 21889282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curing of oscillating larynx by levetiracetam.
    Plummer C; Vogrin S; Cook M; Moses D
    Arch Neurol; 2011 Aug; 68(8):1075. PubMed ID: 21825247
    [No Abstract]   [Full Text] [Related]  

  • 19. Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study.
    Striano P; Manganelli F; Boccella P; Perretti A; Striano S
    Mov Disord; 2005 Dec; 20(12):1610-4. PubMed ID: 16078205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subcutaneous administration of levetiracetam in geriatrics].
    Maison O; De la Gastine B; Peter-Derex L; Berger C; Goutelle S
    Rev Neurol (Paris); 2015 Apr; 171(4):398-9. PubMed ID: 25847398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.